SSRI Prevents Depression in Head, Neck Cancer (CME/CE)

(MedPage Today) -- Prophylactic escitalopram cut the incidence of depression in head and neck cancer patients by more than 50% and improved quality of life, a clinical trial showed.
Source: MedPage Today Psychiatry - Category: Psychiatry Source Type: news